IJCM  Vol.2 No.2 , May 2011
An Epidemiologic Study of Depressive Symptoms among Cardiometabolic Department Patients in México
ABSTRACT
Background. This study estimated the prevalence of depressive symptoms among cardiometabolic department patients in México. Methods. To identify patients with depressive symptoms, we used the Beck’s Depression Inventory (BDI). We analyzed data from consecutive adult patients who attended during a year to a Cardiometabolic Department in México and described the demographic, metabolic and vascular status differences between depressive and non-depressive patients. The estimates are based on a total of 180 patients aged 22 to 83 years. Results. There was a depressive symptoms prevalence rate of 60.5%. Compared with non-depressive patients, depressive patients were more likely to be obese, and to have dysglucemia, hypercholesterolemia, hypoalphalipoproteinemia, microalbuminuria, high uric acid levels, carotid atherosclerosis, insulin resistance and metabolic syndrome. Conclusions. Our data suggest that prevalence of depression is elevated among cardiometabolic patients in México. Depression probably plays a role in cardiometabolic physiopathogenic, and must be intentionally assessed in cardiometabolic patients in order to treat it and to improve the cardiometabolic treatment response and adherence.

Cite this paper
nullJ. Carranza-Madrigal, S. López-Correa and J. Alveano-Hernández, "An Epidemiologic Study of Depressive Symptoms among Cardiometabolic Department Patients in México," International Journal of Clinical Medicine, Vol. 2 No. 2, 2011, pp. 97-101. doi: 10.4236/ijcm.2011.22020.
References
[1]   [1] M. E. Medina-Mora, G. Borges, C. Lara Mu?oz, C. Benjet, J. Blanco Jaimes, C. Fleiz Bautista, J. Villatoro Velázquez, E. Rojas Guiot, J. Zambrano Ruíz, L. Casanova Rodas, S. Aguilar-Gaxiola “Prevalencia de Trastornos Mentales y Uso de Servicios: Resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México,” Salud Mental, Vol. 26, No. 4, 2003, pp. 1-16.

[2]   [2] L M. Bello, E. Puentes-Rosas, M. E. Medina-Mora and R. Lozano, “Prevalencia y Diagnóstico de Depresión en Población Adulta en México,” Salud Pública Mexico, Vol. 47, Suppl. 1, 2005, pp. S4-S11.

[3]   [3] Téllez Zenteno José Francisco, Morales Buenrostro Luís Eduardo, H. Cardiel Mario, “Frecuencia y Factores de Riesgo Para Depresión en Pacientes con Diabetes Mellitus Tipo 2 en un Hospital de Tercer Nivel de Atención,” Medicina Interna de México Marzo, Vol. 17, No. 2, 2001, pp. 54-62.

[4]   [4] S. M. López, H. Alveano and J. Carranza “Prevalencia de Síntomas Depresivos en Síndrome Metabólico,” Revista Facultad Nacional de Salud Pública, Vol. 26, No. 2, 2008, pp. 124-133.

[5]   [5] S. Bonicatto, A. M. Dew and J. J. Soria, “Analysis of the Psychometric Properties of the Spanish Version of the Beck Depression Inventory in Argentina,” Psychiatry Research, Vol. 79, 1998, pp. 277-285. doi:10.1016/S0165-1781(98)00047-X

[6]   [6] R. C. Arnau, M. W. Meagher, M. P. Norris and R. Bram-son “Psychometric Evaluation of the Beck Depression Inventory-II with Primary Care Medical Patients,” Health Psychology, Vol. 20, No. 2, 2001, pp. 112-119. doi:10.1037/0278-6133.20.2.112

[7]   [7] L. K. Sharp and M. S. Lipsky, “Screening for Depression Across the Lifespan: A Review of Measures for Use in Primary Care Settings,” American Family Physician, Vol. 66, No. 6, 2002, pp. 1001-1009.

[8]   [8] E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, et al. “HOMA-Estimated Insulin Re-sistance is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects: Prospective Data from the Verona Diabetes Complications Study,” Diabetes Care, Vol. 25, No. 7, 2002, pp. 1135-1141. doi:10.2337/diacare.25.7.1135

[9]   [9] W. T. Friedewald, R. I. Levy and D. S. Fredrickson “Es-timation of the Concentration of Low-Density Lipopro-tein Cholesterol in Plasma, without Use of Preparative Ultracentrifuge,” Clinical Chemistry, Vol. 18, No. 6, 1972, pp. 499-502.

[10]   [10] K. Al-Shali, A. A House, A. J. Hanley, HM Khan, S. B. Harris, M. Mamakeesick, et al., “Differences between Carotid Wall Morphological Phenotypes Measured by Ultrasound in One, Two and Three Dimensions,” Atherosclerosis, Vol. 178, No. 2, 2005, pp. 319-325. doi:10.1016/j.atherosclerosis.2004.08.016

[11]   [11] M. C. Correti, T. J. Anderson, E. J. Benjamin, D. C. Celermajer, F. Charbonneau, M. A. Creager, et al., “Guidelines for the Ultrasound as Sessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery,” Journal of the American College of Cardiology, Vol. 39, No. 2, 2002, pp. 257-265. doi:10.1016/S0735-1097(01)01746-6

[12]   [12] J. A. Dunbar, P. Reddy, N. Davis-Lameloise, B. Philpot, T. Laatikainen, et al., “Depression: An Important Com- orbidity with Metabolic Syndrome in a General Population,” Diabetes Care, Vol. 31, No. 12, 2008, pp. 2368-2373. doi:10.2337/dc08-0175

[13]   [13] B. Hildrum, A. Mykletun, K. Midthjell, K. Ismail and A. A. Dahl, “No Association of Depression and Anxiety with the Metabolic Syndrome: The Norwegian HUNT Study,” Acta Psychiatr Scand, Vol. 120, No. 1, 2009, pp. 14-22. doi:10.1111/j.1600-0447.2008.01315.x

[14]   [14] A. A. Kabir, S. R. Srinivasan, A. Sultana, W. Chen, C. Y. Wei and G. S. Berenson, “Association between Depres-sion and Intima-Media Thickness of Carotid Bulb in Asymptomatic Young Adults,” The American Journal of Medicine, Vol. 122, No. 12, 2009, pp. 1151. e1-e8.

[15]   [15] M. Kivim?ki, G. D. Batty, A. Singh-Manoux, A. G. Ta-bak, T. N. Akbaraly, J. Vahtera, M. G. Marmot and M. Jokela, “Association between Common Mental Disorder and Obesity over the Adult Life Course,” The British Journal of Psychiatry, Vol. 195, No. 2, 2009, pp. 149-155. doi:10.1192/bjp.bp.108.057299

[16]   [16] P. M. Plotsky, M. J. Owens and C. B. Nemeroff, “Psy-choneuroendocrinology of Depression. Hypothalamic- Pituitary-Adrenal Axis,” Psychiatric Clinics of North America, Vol. 21, No. 2, 1998, pp. 293-307.

[17]   [17] L Arborelius, M. J. Owens, P. M. Plotsky and C. B. Nemeroff, “The Role of Corticotropin-Releasing Factor in Depression and Anxiety Disorders,” Journal of Endocrinology, Vol. 160, No. 1, 1999, pp. 1-12. doi:10.1677/joe.0.1600001

[18]   [18] U. Ehlert, J. Gaab and M. Heinrichs, “Psychoneuroendo-crinological Contributions to the Etiology of Depression, Posttraumatic Stress Disorder, and Stress-Related Bodily Disorders: The Role of the Hypothalamus-Pituitary- Ad-renal Axis,” Biological Psychology, Vol. 57, No. 1-3, 2001, pp. 141-152. doi:10.1016/S0301-0511(01)00092-8

[19]   [19] P. W. Gold, K. E. Gabry, M. R. Yasuda, G. P. Chrousos: “Divergent Endocrine Abnormalities in Melancholic and Atypical Depression: Clinical and Pathophysiologic Im-plications,” Endocrinology Metabolism Clinics of North America, Vol. 31, No. 1, 2000, pp. 37-62. doi:10.1016/S0889-8529(01)00022-6

[20]   [20] E. S. Brown, F. P. Varghese and B. S. McEwen, “Association of Depression with Medical Illness: Does Cortisol Play a Role?” Biol Psychiatry, Vol. 55, No. 1, 2004, pp. 1-9. doi:10.1016/S0006-3223(03)00473-6

 
 
Top